CVS Health Co. (NYSE:CVS) Shares Sold by Valley Brook Capital Group Inc.

Valley Brook Capital Group Inc. reduced its position in CVS Health Co. (NYSE:CVS) by 6.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 4,771 shares of the pharmacy operator’s stock after selling 350 shares during the quarter. Valley Brook Capital Group Inc.’s holdings in CVS Health were worth $377,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of CVS. TCI Wealth Advisors Inc. boosted its position in shares of CVS Health by 2.5% during the 4th quarter. TCI Wealth Advisors Inc. now owns 16,880 shares of the pharmacy operator’s stock worth $1,333,000 after purchasing an additional 411 shares in the last quarter. Sheets Smith Wealth Management boosted its position in shares of CVS Health by 68.0% during the 4th quarter. Sheets Smith Wealth Management now owns 107,301 shares of the pharmacy operator’s stock worth $8,472,000 after purchasing an additional 43,426 shares in the last quarter. River Global Investors LLP purchased a new stake in shares of CVS Health during the 4th quarter worth $261,000. FourThought Financial Partners LLC boosted its position in shares of CVS Health by 10.1% during the 4th quarter. FourThought Financial Partners LLC now owns 6,546 shares of the pharmacy operator’s stock worth $517,000 after purchasing an additional 599 shares in the last quarter. Finally, TCG Advisory Services LLC boosted its position in shares of CVS Health by 730.0% during the 4th quarter. TCG Advisory Services LLC now owns 80,208 shares of the pharmacy operator’s stock worth $6,333,000 after purchasing an additional 70,544 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 1.4 %

Shares of NYSE CVS traded up $0.75 on Friday, reaching $55.90. 23,946,075 shares of the company traded hands, compared to its average volume of 12,498,538. CVS Health Co. has a fifty-two week low of $53.70 and a fifty-two week high of $83.25. The company has a 50 day moving average of $72.77 and a 200 day moving average of $73.29. The company has a current ratio of 0.81, a quick ratio of 0.63 and a debt-to-equity ratio of 0.78. The stock has a market capitalization of $70.18 billion, a PE ratio of 9.82, a P/E/G ratio of 0.88 and a beta of 0.56.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same period in the prior year, the company earned $2.20 EPS. The company’s revenue was up 3.7% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Co. will post 7.03 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.76%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Insider Buying and Selling

In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of several research analyst reports. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $85.00 to $60.00 in a research report on Thursday. SVB Leerink reiterated a “market perform” rating and issued a $60.00 price objective (down from $87.00) on shares of CVS Health in a research report on Wednesday. Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Finally, The Goldman Sachs Group reduced their target price on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a report on Thursday. Eight investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $80.35.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.